
About Mysim Therapeutics Private Limited
Data last updated:
Mysim Therapeutics Private Limited is a private limited company based in Delhi, India. It operates in the preventive healthcare segment of the healthcare sector. It was incorporated on 20 November 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24299DL2020PTC373484. Its GSTIN is 07AAOCM0920A1ZX (Delhi).
The company has an authorised share capital of ₹14 Lakh and a paid-up capital of ₹10 Lakh. It is led by directors Irshad Ahmad Gojri and Mumtaz Ahmad Siddique.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 220/3 Flat No. 301 Nai Basti Road Abdul Fazal Enclave Jamia Nagar, Delhi, India – 110025.
As per the financials filed for FY 2025, the company reported a revenue of ₹8.37 Cr, a growth of 15% compared to the previous year. For the same year it recorded a net profit of ₹68.33 Lakh (net margin 8.2%) and EBITDA of ₹94.12 Lakh (EBITDA margin 11.2%). Revenue has grown at a compounded annual rate (CAGR) of 45% over three years.
The company has about 50 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Mysim Therapeutics.
For more details, the company can be reached via its website mysimtherapeutics.com.
Company details
Contact details
Mysim Therapeutics Private Limited's registered office is in Delhi, Delhi. Its website is mysimtherapeutics.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered Address220/3 Flat No. 301 Nai Basti Road Abdul Fazal Enclave Jamia Nagar, Delhi, India – 110025
- IndustryHealthcare, Preventive Health Services
To see the full contact details of Mysim Therapeutics Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Mysim Therapeutics operates one associated brand: Mysim Therapeutics. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Provision of valued medicines in healthcare sectors like Nephrology and Cardiology. | mysimtherapeutics.com |
Business activity
The main business activity of Mysim Therapeutics is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers wholesale trade, except of motor vehicles and motorcycles.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Wholesale and retail trade; repair of motor vehicles and motorcycles | 46 | Wholesale trade, except of motor vehicles and motorcycles |
To see the full business activity and turnover split of Mysim Therapeutics Private Limited, buy the company report.
Financials of Mysim Therapeutics Private Limited
FY 2025 filings availableMysim Therapeutics Private Limited reported revenue of ₹8.37 Cr (up 15% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 45% over three years, including 15% growth in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹94.12 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹68.33 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 11.2% | ||||
| Net Profit Margin | 8.2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Mysim Therapeutics Private Limited, buy the company report.
Board of directors of Mysim Therapeutics Private Limited
Mysim Therapeutics has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Irshad Ahmad Gojri Also directs: Mysim Healthcare Private Limited | Director | 22 Mar 2024 | 2 Years 7 Months | Current |
| Mumtaz Ahmad Siddique Also directs: Mysim Healthcare Private Limited | Director | 20 Nov 2020 | 5 Years 11 Months | Current |
Auditor
Mysim Therapeutics Private Limited is audited by S MADNANI & ASSOCIATES for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| S MADNANI & ASSOCIATES | FY 2022 | 014292N |
Shareholding
The shareholding of Mysim Therapeutics Private Limited is on record for FY 2021, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2021 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Public | |
| Others |
To see the full shareholding pattern of Mysim Therapeutics Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Mysim Therapeutics Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Mysim Therapeutics Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Mysim Therapeutics Private Limited has a workforce of 50 employees on its EPFO records as of May 2026, across 1 active EPFO establishment.
Headcount by financial year
| Financial year | Employees (EPFO) |
|---|---|
| FY 2026-27 | 50 |
| FY 2025-26 | |
| FY 2024-25 | |
| FY 2023-24 | |
| FY 2022-23 |
To see the full employee and EPFO history of Mysim Therapeutics Private Limited, buy the company report.
GST
Mysim Therapeutics has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AAOCM0920A1ZX | Delhi | Active | 16 Jan 2021 |
To see the full GST registrations and return filing status of Mysim Therapeutics Private Limited, buy the company report.
Recent activity
Mysim Therapeutics Private Limited has 4 board changes on record since 2020: 2 appointments and 2 cessations. The latest: Irshad Ahmad Gojri ceased to be Additional Director on 29 Sep 2024.
Frequently asked questions
Mysim Therapeutics is an active private limited company based in Delhi, India. The company works in preventive health services, within the healthcare industry. It was incorporated on 20 November 2020 (6+ years old) and is registered under CIN U24299DL2020PTC373484.
Mysim Therapeutics has 2 current directors:
- Irshad Ahmad Gojri - Director
- Mumtaz Ahmad Siddique - Director
The latest financial statements of Mysim Therapeutics on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2021 are in the company report.
The GSTIN of Mysim Therapeutics is 07AAOCM0920A1ZX, registered in Delhi.
The CIN (Corporate Identification Number) of Mysim Therapeutics is U24299DL2020PTC373484. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Mysim Therapeutics was incorporated on 20 November 2020, making it 6+ years old. It is registered with the Registrar of Companies, Delhi.
Irshad Ahmad Gojri ceased to be Additional Director on 29 Sep 2024. Suresh Kumar Sahoo ceased to be Director on 31 Mar 2024. Irshad Ahmad Gojri was appointed as Director on 22 Mar 2024. Mysim Therapeutics has 4 board changes on record in total.
Mysim Therapeutics can be reached through the website mysimtherapeutics.com. Its registered office is in Delhi, India.
The registered office of Mysim Therapeutics is at 2203 Flat No. 301 Nai Basti Road Abdul Fazal Enclave Jamia Nagar, Delhi, India – 110025.
Mysim Therapeutics operates in the healthcare industry, in the preventive health services segment.

